This statistic shows the annual shipment value of the in-vitro diagnostic substance manufacturing industry in the United States from 2008 to 2015, with a forecast until 2020. In 2016, the shipment value of in-vitro diagnostic substance manufacturing in the U.S. ranged at approximately 13.64 billion U.S. dollars.
Total value of shipments of the in-vitro diagnostic substance manufacturing industry (NAICS 325413) in the United States from 2008 to 2020
(in million U.S. dollars)
Methodology and further information: Historic data were retrieved from the United States Census Bureau up until 2011. All forecasts rely on sophisticated statistical modelling conducted by Statista Research & Analysis. Forecast methods include trend analysis and linear regressions under consideration of relevant market drivers.
The total value of shipments includes the received or receivable net selling values, 'Free on Board' plant (excl. freight and taxes), of all products shipped, as well as all miscellaneous receipts; Covers establishments with one or more paid employees or nonemployers that use leased employees for manufacturing.
More information on market forecasts on Statista can be found here.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (February 15, 2017). Total value of shipments of the in-vitro diagnostic substance manufacturing industry (NAICS 325413) in the United States from 2008 to 2020 (in million U.S. dollars) [Graph]. In Statista. Retrieved October 07, 2024, from https://www.statista.com/forecasts/310872/us-in-vitro-diagnostic-substance-manufacturing-industry-shipment-value-forecast-naics-325413
Statista. "Total value of shipments of the in-vitro diagnostic substance manufacturing industry (NAICS 325413) in the United States from 2008 to 2020 (in million U.S. dollars)." Chart. February 15, 2017. Statista. Accessed October 07, 2024. https://www.statista.com/forecasts/310872/us-in-vitro-diagnostic-substance-manufacturing-industry-shipment-value-forecast-naics-325413
Statista. (2017). Total value of shipments of the in-vitro diagnostic substance manufacturing industry (NAICS 325413) in the United States from 2008 to 2020 (in million U.S. dollars). Statista. Statista Inc.. Accessed: October 07, 2024. https://www.statista.com/forecasts/310872/us-in-vitro-diagnostic-substance-manufacturing-industry-shipment-value-forecast-naics-325413
Statista. "Total Value of Shipments of The In-vitro Diagnostic Substance Manufacturing Industry (Naics 325413) in The United States from 2008 to 2020 (in Million U.S. Dollars)." Statista, Statista Inc., 15 Feb 2017, https://www.statista.com/forecasts/310872/us-in-vitro-diagnostic-substance-manufacturing-industry-shipment-value-forecast-naics-325413
Statista, Total value of shipments of the in-vitro diagnostic substance manufacturing industry (NAICS 325413) in the United States from 2008 to 2020 (in million U.S. dollars) Statista, https://www.statista.com/forecasts/310872/us-in-vitro-diagnostic-substance-manufacturing-industry-shipment-value-forecast-naics-325413 (last visited October 07, 2024)
Total value of shipments of the in-vitro diagnostic substance manufacturing industry (NAICS 325413) in the United States from 2008 to 2020 (in million U.S. dollars) [Graph], Statista, February 15, 2017. [Online]. Available: https://www.statista.com/forecasts/310872/us-in-vitro-diagnostic-substance-manufacturing-industry-shipment-value-forecast-naics-325413
